These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 3098324
1. Amantadine potentiates T lymphocyte killing by an anti-pan-T cell (CD5) ricin A-chain immunotoxin. Siena S, Villa S, Bregni M, Bonnadonna G, Gianni AM. Blood; 1987 Jan; 69(1):345-8. PubMed ID: 3098324 [Abstract] [Full Text] [Related]
2. Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin. Siena S, Villa S, Bonadonna G, Bregni M, Gianni AM. Transplantation; 1987 Mar; 43(3):421-6. PubMed ID: 3103275 [Abstract] [Full Text] [Related]
4. Marrow purging in autologous bone marrow transplantation for T-lineage acute lymphoblastic leukemia: efficacy of ex vivo treatment with immunotoxins and 4-hydroperoxycyclophosphamide against fresh leukemic marrow progenitor cells. Uckun FM, Gajl-Peczalska K, Meyers DE, Ramsay NC, Kersey JH, Colvin M, Vallera DA. Blood; 1987 Jan; 69(1):361-6. PubMed ID: 3098325 [Abstract] [Full Text] [Related]
5. Antigenic modulation by anti-CD5 immunotoxins. Manske JM, Buchsbaum DJ, Azemove SM, Hanna DE, Vallera DA. J Immunol; 1986 Jun 15; 136(12):4721-8. PubMed ID: 3086441 [Abstract] [Full Text] [Related]
6. Immunotoxins show rapid entry of diphtheria toxin but not ricin via the T3 antigen. Youle RJ, Uckun FM, Vallera DA, Colombatti M. J Immunol; 1986 Jan 15; 136(1):93-8. PubMed ID: 3079613 [Abstract] [Full Text] [Related]
7. Kinetics of protein synthesis inactivation in human T-lymphocytes by selective monoclonal antibody-ricin conjugates. Leonard JE, Wang QC, Kaplan NO, Royston I. Cancer Res; 1985 Nov 15; 45(11 Pt 1):5263-9. PubMed ID: 3876881 [Abstract] [Full Text] [Related]
8. Use of colony assays and anti-T cell immunotoxins to elucidate the immunobiologic features of leukemic progenitor cells in T-lineage acute lymphoblastic leukemia. Uckun FM, Myers DE, Ledbetter JA, Swaim SE, Gajl-Peczalska KJ, Vallera DA. J Immunol; 1988 Mar 15; 140(6):2103-11. PubMed ID: 3126241 [Abstract] [Full Text] [Related]
9. T cell depletion with anti-CD5 immunotoxin in histocompatible bone marrow transplantation. The correlation between residual CD5 negative T cells and subsequent graft-versus-host disease. Filipovich AH, Vallera D, McGlave P, Polich D, Gajl-Peczalska K, Haake R, Lasky L, Blazar B, Ramsay NK, Kersey J. Transplantation; 1990 Sep 15; 50(3):410-5. PubMed ID: 1698319 [Abstract] [Full Text] [Related]
10. Preclinical studies on the use of selective antibody-ricin conjugates in autologous bone marrow transplantation. Leonard JE, Taetle R, To D, Rhyner K. Blood; 1985 May 15; 65(5):1149-57. PubMed ID: 3888307 [Abstract] [Full Text] [Related]
11. Selective killing of human T-lymphotropic virus-I infected leukemic T-cells by monoclonal anti-interleukin 2 receptor antibody-ricin A chain conjugates: potentiation by ammonium chloride and monensin. Krönke M, Schlick E, Waldmann TA, Vitetta ES, Greene WC. Cancer Res; 1986 Jul 15; 46(7):3295-8. PubMed ID: 3011246 [Abstract] [Full Text] [Related]
12. Optimal elimination of leukemic T cells from human bone marrow with T101-ricin A-chain immunotoxin. Casellas P, Canat X, Fauser AA, Gros O, Laurent G, Poncelet P, Jansen FK. Blood; 1985 Feb 15; 65(2):289-97. PubMed ID: 3871341 [Abstract] [Full Text] [Related]
13. Different susceptibilities of normal T cells and T cell lines to immunotoxins. Preijers FW, Tax WJ, Wessels JM, Capel PJ, De Witte T, Haanen C. Scand J Immunol; 1988 May 15; 27(5):533-40. PubMed ID: 3259720 [Abstract] [Full Text] [Related]